Authors:
Di Modugno, F
Buglioni, S
Mottolese, M
Del Bello, D
Cascioli, S
Chersi, A
Santoni, A
Nistico, P
Citation: F. Di Modugno et al., Polyclonal antibodies against gp185(HER2) peptides: Their putative role inthe identification of a particular HER2 status in patients with breast cancer, J IMMUNOTH, 24(3), 2001, pp. 221-231
Authors:
Buglioni, S
D'Agnano, I
Vasselli, S
Donnorso, RP
D'Angelo, C
Brenna, A
Benevelo, M
Cosimelli, M
Zupi, G
Mottolese, M
Citation: S. Buglioni et al., p53 nuclear accumulation and multiploidy are adverse prognostic factors insurgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy, AM J CLIN P, 116(3), 2001, pp. 360-368
Authors:
Del Bufalo, D
Trisciuoglio, D
Biroccio, A
Marcocci, L
Buglioni, S
Candiloro, A
Scarsella, M
Leonetti, C
Zupi, G
Citation: D. Del Bufalo et al., Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity, J CELL BIOC, 83(3), 2001, pp. 473-483
Authors:
Biroccio, A
Benassi, B
D'Agnano, I
D'Angelo, C
Buglioni, S
Mottolese, M
Ricciotti, A
Citro, G
Cosimelli, M
Ramsay, RG
Calabretta, B
Zupi, G
Citation: A. Biroccio et al., c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer - Clinical and experimental findings, AM J PATH, 158(4), 2001, pp. 1289-1299
Authors:
Mottolese, M
Benevolo, M
Del Monte, G
Buglioni, S
Papaldo, P
Nistico, C
Di Filippo, F
Vasselli, S
Vici, P
Botti, C
Citation: M. Mottolese et al., Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy, J CANC RES, 126(12), 2000, pp. 722-729
Authors:
Morini, M
Mottolese, M
Ferrari, N
Ghiorzo, F
Buglioni, S
Mortarini, R
Noonan, DM
Natali, PG
Albini, A
Citation: M. Morini et al., The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity, INT J CANC, 87(3), 2000, pp. 336-342
Authors:
Buglioni, S
D'Agnano, I
Cosimelli, M
Vasselli, S
D'Angelo, C
Tedesco, M
Zupi, G
Mottolese, M
Citation: S. Buglioni et al., Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and Bcl-2, INT J CANC, 84(6), 1999, pp. 545-552